3 Wang J Y, Wu Q F, Li J P, et al. Photo-sensitive liposomes: chemistry and application. Mini Rev Med Chem, 2010, 10: 172-181??
[4]
4 Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliver Rev, 2001, 53: 307-319??
[5]
5 Basel M T, Shrestha T B, Troyer D L, et al. Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomesusing triggered release. ACS Nano, 2011, 5: 2162-2175??
[6]
6 Hiraka K, Kanehisa M, Tamai M, et al. Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect. ColloidsSurf B Biointerfaces, 2008, 67: 54-58??
[7]
7 Kobatake E, Yamano R, Mie M. Targeted delivery using immunoliposomes with a lipid-modified antibody-binding protein. Appl BiochemBiotechnol, 2010, 163: 296-303
[8]
8 Li H, Lu Y, Piao L, et al. Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined withreceptor modulation by all-trans retinoic acid. Int J Pharm, 2010, 402: 57-63??
[9]
9 Mendonca L S, Moreira J N, de Lima M C, et al. Co-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrinreceptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatment. Biotechnol Bioeng, 2010, 107: 884-893??
[10]
10 Bardonnet P L, Faivre V, Boullanger P, et al. Glycosylated liposomes against Helicobacter pylori: behavior in acidic conditions. BiochemBiophys Res Commun, 2009, 383: 48-53??
[11]
11 Yativin M B, Weinstein J N, Dennis W H, et al. Design of liposomes for enhanced local release of drugs by hyperthermia. Science, 1978,202: 1290-1293??
[12]
12 Koning G A, Eggermont A M M, Lindner L H, et al. Hyperthermia and thermosensitive liposomes for improved delivery ofchemotherapeutic drugs to solid tumors. Pharm Res, 2010, 27: 1750-1754??
[13]
13 Kono K, Ozawa T, Yoshida T, et al. Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specificchemotherapy. Biomaterials, 2010, 31: 7096-7105??
17 Suzuki R, Oda Y, Utoguchi N, et al. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- andmicrobubbles. J Control Release, 2011, 149: 36-41??
26 Tran V T, Benoti J P. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int JPharm, 2011, 407: 1-11
[27]
27 Freitas S, Merkle H P, Gander B. Microencapsulation by solvent extraction/ evaporation: reviewing the state of the art of microspherepreparation process technology. J Control Release, 2005, 102: 313-332??
32 Guan J, Zhou L, Pan Y, et al. A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivoevaluation. Pharm Res, 2010, 27: 105-114??
[33]
33 Zhang Z, Peng B, Yang X, et al. Design and evaluation of a novel floating osmotic pump system. J Pharm Pharm Sci, 2009, 12: 129-137
[34]
34 Guan J, Zhou L, Nie S, et al. A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation. Int J Pharm, 2010, 383: 30-36??
[35]
35 Tuntikulwattana S, Mitrevej A, Kerdcharoen T, et al. Development and optimization of micro/nanoporous osmotic pump tablets. AAPSPharmSciTech, 2010, 11: 924-935
[36]
36 Wei L, Li J, Guo L, et al. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm, 2007,33: 990-998??
40 Muschert S, Siepmann F, Leclercq B, et al. Simulated food effects on drug release from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Drug Dev Ind Pharm, 2010, 36: 173-179??
[41]
41 Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: Current perspectives. J Control Release, 2009, 134:74-80??
[42]
42 Mohamad A, Dashevsky A. In vitro and in vivo performance of a multiparticulate pulsatile drug delivery system. Drug Dev Ind Pharm, 2007,33: 113-119??
44 Karrout Y, Neut C, Wils D, et al. Novel polymeric film coatings for colon targeting: Drug release from coated pellets. Eur J Pharm Sci,2009, 37: 427-433??
[45]
45 梅兴国. 药物新剂型与制剂新技术. 北京: 化学工业出版社, 2007
[46]
46 陈新梅. 肺部给药研究新进展. 中国现代药物应用, 2010, 4: 224-226
[47]
47 Tsapis N, Bennett D, Jackson B, et al. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA,2002, 99: 12001-12005??
[48]
48 Zhang J, Wu L, Chan H K, et al. Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliver Rev, 2011, 63:441-455??
[49]
49 Behara S R B, Kippax P, Mcintosh M P, et al. structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisationand de-agglomeration behaviour under dynamic conditions. Eur J Pharm Sci, 2011, 42: 210-219??
[50]
50 Okamoto H, Danjo K. Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation. AdvancedDrug Delivery Reviews, 2008, 60: 433-446??
[51]
51 Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm, 2010, 392: 1-19??
[52]
52 Sebti, T H, Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm, 2006, 63:51-58??
[53]
53 Naikwade S R, Bajaj A N, Gurav P. Development of budesonide microparticles using spray-drying technology for pulmonary administration:design, characterization, in vitro evaluation, and in vivo efficacy study. AAPS Pharm Sci Tech, 2009, 10: 993-1012??
[54]
54 Klinger C, Müller B W, Steckel H. Insulin micro-and nanoparticles for pulmonary delivery. Int J Pharm, 2009, 377:173-179??
[55]
55 Zijlstra G S, Ponsioen B J, Hummel S A, et al. Formulation and process development of (recombinant human) deoxyribonuclease I as apowder for inhalation. Pharm Dev Technol, 2009, 14:358-368??
[56]
59 Newman S P. Dry powder inhalers for optimal drug delivery. Expert Opin Biol Ther, 2004, 4: 23-33??
57 Saluja V, Amorij J P, Kapteyn J C, et al. A comparison between spray drying and spray freeze drying to produce an influenza subunitvaccine powder for inhalation. J Control Release, 2010, 144:127-133??
[59]
58 Chrystyn H. Closer to an ‘Ideal Inhaler’ with the easy haler: an innovative dry powder inhaler. Clin Drug Invest, 2006, 26: 175-183??
[60]
60 Hickey A J, Crowder T M. Next generation dry powder inhalation delivery systems. Lung Biol Health Dis, 2007, 221: 445-460